Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mycoplaa hyopneumoniae selective isolation medium and preparation method thereof

A technology for separating mycoplasma hyopneumoniae and culture medium, applied in the direction of microorganism-based methods, biochemical equipment and methods, and separating microorganisms, can solve the problems of insufficient information, low titer of viable bacteria, small molecular weight, etc., and achieve successful separation High efficiency, strong sensitivity, and short separation time

Inactive Publication Date: 2019-02-01
NANJING DAYAO NETWORK TECH CO LTD
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although Mycoplasma hyopneumoniae can use the nutrients in the culture medium to synthesize the substances needed for its own growth and reproduction, due to the small molecular weight of its genome, the amount of information it carries is not much, and its biosynthetic ability is limited. Therefore, it needs to ingest cholesterol, amino acids, Fatty acids, nucleic acid precursors, vitamins and other substances, which make the medium composition of mycoplasma more complicated, and some special nutrients must be added
The growth rate of Mycoplasma hyopneumoniae in the medium is slow, and the titer of viable bacteria is at 10 7 -10 8 About CCU / ml, the titer of viable bacteria is low, not ideal
[0004] Mycoplasma is a tiny prokaryotic organism without a cell wall. It can grow on an artificial medium to form small colonies, but the culture conditions are very harsh and the growth rate is slow. Mycoplasma hyorhinophylla and Mycoplasma hyopneumoniae often exist in pigs at the same time, and Its growth rate is higher than that of Mycoplasma hyopneumoniae, so that the isolation and identification of Mycoplasma hyopneumoniae often causes pollution, which leads to the failure of Mycoplasma hyopneumoniae isolation, which makes it difficult for the research on the prevention and treatment of swine asthma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mycoplaa hyopneumoniae selective isolation medium and preparation method thereof
  • Mycoplaa hyopneumoniae selective isolation medium and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] A selective isolation medium for Mycoplasma hyopneumoniae, comprising the following components: 6.0 g of brain heart extract, 6.0 g of PPLO broth, 2.0 ml of 10× Hank's solution, 3.0 g of yeast extract, 2.0 g of hydrolyzed milk protein, and 3.0 g of amino acid composition , glucose 10.0g, penicillin 250U / ml, nystatin 0.002g, 0.1% phenol red 5ml, inactivated pig serum 150ml, specific growth inhibitory serum 15ml, deionized water 600ml.

[0019] Further, the amino acid composition contains L-arginine, glycine, tyrosine, L-cysteine ​​and serine, L-arginine, glycine, tyrosine, L-cysteine ​​and serine The mass ratio is 2:1:1:1:1.

[0020] Further, the specific growth-inhibiting serum in the present invention refers to the specific growth-inhibiting serum that inhibits Mycoplasma hyorhinosum.

[0021] The preparation method comprises the following steps:

[0022] a. Take 6.0g of brain heart extract and 6.0g of PPLO broth according to the ratio, dissolve them in 300ml of deio...

Embodiment 2

[0026] A selective isolation medium for Mycoplasma hyopneumoniae, comprising the following components: 7.0 g of brain heart extract, 8.0 g of PPLO broth, 3.5 ml of 10× Hank's solution, 4.0 g of yeast extract, 3.0 g of hydrolyzed milk protein, and 4.0 g of amino acid composition , glucose 15.0g, penicillin 300U / ml, nystatin 0.003g, 0.1% phenol red 10ml, inactivated pig serum 175ml, specific growth inhibitory serum 17ml, deionized water 700ml.

[0027] Further, the amino acid composition contains L-arginine, glycine, tyrosine, L-cysteine ​​and serine, L-arginine, glycine, tyrosine, L-cysteine ​​and serine The mass ratio is 1:1:1:2:1.

[0028] Further, the specific growth-inhibiting serum in the present invention refers to the specific growth-inhibiting serum that inhibits Mycoplasma hyorhinosum.

[0029] The preparation method comprises the following steps:

[0030] a. Take 8.0g of brain heart extract and 8.0g of PPLO broth according to the ratio, dissolve them in 350ml of dei...

Embodiment 3

[0034] A selective isolation medium for Mycoplasma hyopneumoniae, comprising the following components: 10.0 g of brain heart extract, 10.0 g of PPLO broth, 5.0 ml of 10× Hank's solution, 5.0 g of yeast extract, 4.0 g of hydrolyzed milk protein, and 5.0 g of amino acid composition , glucose 20.0g, penicillin 400U / ml, nystatin 0.005g, 0.1% phenol red 18ml, inactivated pig serum 200ml, specific growth inhibitory serum 20ml, deionized water 800ml.

[0035] Further, the amino acid composition contains L-arginine, glycine, tyrosine, L-cysteine ​​and serine, L-arginine, glycine, tyrosine, L-cysteine ​​and serine The mass ratio is 1:1:1:1:1.

[0036] Further, the specific growth-inhibiting serum in the present invention refers to the specific growth-inhibiting serum that inhibits Mycoplasma hyorhinosum.

[0037] The preparation method comprises the following steps:

[0038] a. Take 10.0g of brain heart extract and 10.0g of PPLO broth according to the ratio, dissolve them in 400ml of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Belonging to the field of veterinary biological products, the invention discloses a mycoplaa hyopneumoniae selective isolation medium and a preparation method thereof. The mycoplaa hyopneumoniae selective isolation medium comprises the following components: brain heart infusion, PPLO broth, 10*Hank's solution, yeast extracted liquid, lactalbumin hydrolysate, an amino acid composition, glucose, penicillin, nystatin, 0.1% phenol red, inactivated pig serum, specific growth inhibiting serum and deionized water. The mycoplaa hyopneumoniae selective isolation medium provided by the invention has thecharacteristics of short isolation time, high isolation success rate, viable bacteria titer and isolation sensitivity far higher than those of the medium in the prior art, and is suitable for rapid growth of mycoplaa hyopneumoniae.

Description

technical field [0001] The invention relates to the field of veterinary biological products, in particular to a selective separation medium for mycoplasma hyopneumoniae and a preparation method thereof. Background technique [0002] Mycoplasma swine pneumonia is a very common respiratory disease in pig farms. It is prevalent all over the world. It is commonly known as swine asthma. It is caused by Mycoplasma hyopneumoniae (Mhp). The pathogen mainly resides in the trachea, bronchi and bronchioles in pigs On the cilia of pigs, it seriously damages the physical defense mechanism of pig respiratory tract - defense mucosa, which increases the susceptibility of pigs to other respiratory pathogens, so it often causes co-infection of multiple pathogens, causing porcine respiratory syndrome (PRDC) or other diseases , Seriously endanger the development of pig industry. [0003] Mycoplasma hyopneumoniae is a facultative anaerobic bacterium with extremely demanding growth requirements ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20C12N1/02C12Q1/04C12R1/35
CPCC12N1/02C12N1/20C12Q1/045
Inventor 朱燕锋嵇桃桃刘志程
Owner NANJING DAYAO NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products